Robinson Chandlerinsider trades
In SEC Form 4 filings, Robinson Chandler is listed as Chief Executive Officer of Monopar Therapeutics (MNPR). In the last 90 days, Robinson Chandler sold $2.56M of Monopar Therapeutics (MNPR) on the open market and bought none. All 4 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| MNPRMonopar Therapeutics | Chief Executive Officer | 12 | Oct 20 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-28
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| MNPRMonopar Therapeutics | Oct 20 | Oct 20 | F | 597 | $92.59 | $55,276 | 104,127 | No | Form 4 |
| MNPRMonopar Therapeutics | Sep 30 | Oct 2 | M | 9,801 | not reported | not reported | 109,068 | No | Form 4 |
| MNPRMonopar Therapeutics | Sep 30 | Oct 2 | F | 4,344 | $79.67 | $346,086 | 104,724 | No | Form 4 |
| MNPRMonopar Therapeutics | Sep 30 | Oct 2 | M · derivative | 9,801 | $0.00 | $0 | 83,602 | No | Form 4 |
| MNPRMonopar Therapeutics | Sep 24 | Sep 28 | M | 14,056 | $30.00 | $421,680 | 113,323 | Yes | Form 4 |
| MNPRMonopar Therapeutics | Sep 24 | Sep 28 | M | 15,000 | $14.00 | $210,000 | 128,323 | Yes | Form 4 |
| MNPRMonopar Therapeutics | Sep 24 | Sep 28 | S | 10,450 | $87.15 | Sale −$910,718 | 117,873 | Yes | Form 4 |
| MNPRMonopar Therapeutics | Sep 24 | Sep 28 | S | 9,638 | $87.96 | Sale −$847,758 | 108,235 | Yes | Form 4 |
| MNPRMonopar Therapeutics | Sep 24 | Sep 28 | S | 8,368 | $88.97 | Sale −$744,501 | 99,867 | Yes | Form 4 |
| MNPRMonopar Therapeutics | Sep 24 | Sep 28 | S | 600 | $89.79 | Sale −$53,874 | 99,267 | Yes | Form 4 |
| MNPRMonopar Therapeutics | Sep 24 | Sep 28 | M · derivative | 14,056 | $30.00 | $421,680 | 15,044 | Yes | Form 4 |
| MNPRMonopar Therapeutics | Sep 24 | Sep 28 | M · derivative | 15,000 | $14.00 | $210,000 | 27,204 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.